作者:
Minden,M.D. [1]
;
Hogge,D.E. [2]
;
Weir,S.J. [3]
;
Kasper,J. [4]
;
Webster,D.A. [5]
;
Patton,L. [6]
;
Jitkova,Y. [7]
;
Hurren,R. ;
Gronda,M. ;
Goard,C.A. ;
Rajewski,L.G. ;
Haslam,J.L. ;
Heppert,K.E. ;
Schorno,K. ;
Chang,H. ;
Brandwein,J.M. ;
Gupta,V. ;
Schuh,A.C. ;
Trudel,S. ;
Yee,K.W.L. ;
Reed,G.A. ;
Schimmer,A.D.
作者单位:
University of Kansas Cancer Center, Kansas City, KS, United States
[1]
Biotechnology Innovation and Optimization (BIO) Center, University of Kansas, Lawrence, KS, United
[2]
Department of Laboratory Hematology, University Health Network, Toronto, ON, Canada
[3]
Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
[4]
Beckloff Associates, Inc., Overland Park, KS, United States
[5]
Division of Hematology and Leukemia/BMT, University of British Columbia, Vancouver, BC, Canada
[6]
The Leukemia and Lymphoma Society, White Plains, NY, United States
[7]
发布时间
2018-09-20